Metastatic ER+ Her2- Breast Cancer
1 clinical trials · Condition
◉ Watch Metastatic ER+ Her2- Breast Cancer
| Record | Firm | Date |
|---|---|---|
| A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy (NCT01381874) | Janssen Research & Development, LLC | 2011-08-24 |
Track Metastatic ER+ Her2- Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.